期刊文献+

mTOR信号通路介导黄芩苷抑制人结肠癌细胞的增殖 被引量:4

mTOR signaling pathway mediates baicalin-inhibited proliferation in human colon cancer cell line HCT116
下载PDF
导出
摘要 目的探讨黄芩苷抑制人结肠癌细胞(HCT116)增殖的分子机制。方法采用MTT比色法检测不同浓度的黄芩苷(0.01~100μg/ml)对体外培养的HCT116细胞增殖的抑制作用;采用Western blot分析检测被黄芩苷干预的HCT 116细胞的增殖相关蛋白的表达。结果与对照组比较,浓度为1~100μg/ml的黄芩苷处理组明显抑制HCT 116细胞的增殖(P<0.05)。用100μg/ml黄芩苷处理后,增殖相关的蛋白mTOR、p70S6K、S6、eIF4E表达明显下调(P<0.05),4E-BP1表达明显上调。p-mTOR(Ser2448)、p-S6(Ser235/236)、p-4E-BP1(Thr37/46)的磷酸化水平下降(P<0.05)。结论黄芩苷能通过抑制mTOR信号通路来抑制人结直肠癌HCT116细胞的增殖。 Objective To determine the inhibitory effect of baicalin on the proliferation of human colon cancer cell line HCT116 and its underlying mechanism. Methods Human colon cancer cell line HCT116 were primarily cultured in vitro and treated with baicalin at different concentrations of 0.01 to 100μg/ml. MTF assay was performed to assess the cell proliferation. Western blotting was used to analyze the expression of cell proliferation related proteins in HCT116 cells after baiealin treatment. Results Baicalin from 1 to 100 μg/ml resulted in significantly inhibitory effect on HCT116 cells proliferation compared with the control group (P 〈 0. 05 ). The protein expression of roTOR, p70S6K, S6 and eIF4E were significantly down-regulated by baiealin (100 μg/ml) (P 〈 0.05 ) , as well as the expression of 4E-BP1 was significantly up-regulated. The phosphorylation of mTOR, S6 and 4E-BP1 were suppressed by baicalin (100 μg/ml) in HCT116 cells (P 〈 0. 05). Conclusion Baicalin inhibited the proliferation in HCT116 cells through mTOR signaling pathway.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2012年第23期2399-2402,共4页 Journal of Third Military Medical University
关键词 黄芩苷 人结直肠癌HCT116细胞 增殖 MTOR信号通路 baicalin human colon cancer cell line HCT116 proliferation mTOR signaling pathway
  • 相关文献

参考文献5

  • 1Thoreen C C, Kang S A, Chang J W, et al. An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1 [J]. J Biol Chem, 2009, 284 (12) : 8023 - 8032. 被引量:1
  • 2Fingar D C, Salama S, Tsou C, et al. Mammalian cell size is con- trolled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E [J]. Genes Dev, 2002, 16(12) : 1472 -1487. 被引量:1
  • 3Harrison D E, Strong R, Sharp Z D, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice [J]. Nature, 2009, 460(7253) : 392 -395. 被引量:1
  • 4Wullsehleger S, Loewith R, Hall M N. TOR signaling in growth and metabolism[J]. Cell, 2006, 124(3): 471 -484. 被引量:1
  • 5张喜平,田华,程琪辉.黄芩苷的药理作用研究现状[J].中国药理学通报,2003,19(11):1212-1215. 被引量:172

二级参考文献32

  • 1蔡仙德,谭剑萍,穆维同,王立新.黄芩甙对小鼠细胞免疫功能的影响[J].南京铁道医学院学报,1994,13(2):65-68. 被引量:55
  • 2陈光福,虞佩兰,金立明,杨于嘉,刘运生,陶永光.黄芩甙、川芎嗪对兔感染性脑水肿与磷脂酶A_2的作用[J].中国当代儿科杂志,1999,1(3):149-152. 被引量:16
  • 3Ng TB,Liu F,Wang ZT et al. Antioxidative activity of natural products from plants. Life Sci, 2000 ;(8) :709-23. 被引量:1
  • 4Gao Z, Huang K, Xu H etal. Protective effects of flavonoids in the roots of Scutellaria baicalensis Georgi against hydrogen peroxide-induced oxidative stress in HS-SY5Y cells. Pharmacol Res, 2001 ;43(2) : 173-8. 被引量:1
  • 5Wu J ,Chen D,Zhang R et al. Study on the bioavailability of baicalin-phospholipid complex by using HPLC. Biomed Chromatogr, 1999;13(7) :493-5. 被引量:1
  • 6Shimizu I, Ma YR, Mizobuchi Yet al. Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats. Hepatology, 1999;29(1) :149-60. 被引量:1
  • 7Kim HM, Moon EJ, Li E et al. The nitric oxide-producing activities of Scutellaria baicalensis. Toxicology, 1999; 135 (23) :109-15. 被引量:1
  • 8Kyo R, Nakahata N, Sakakibara Iet al. Baicalin and baicalein, constituents of an important medicinal plant, inhibit intracellular Ca^2+ elevation by reducing phospholipase C activity in C6 rat glioma cells. J Pharm Pharmacol, 1998;50(10):1179-82. 被引量:1
  • 9Marx J. Cell death studies yield cancer clues. Science, 1993;259(5) :760-1. 被引量:1
  • 10Dong Y,Yang MMP,Kwan CY et al. In vitro inhibition of proliferation of HL-60 cells by tetrandrine and coriolus versicolor peptide derived from Chinese medical herbs, Life Sci, 1997 ;60(8):1135 -40. 被引量:1

共引文献171

同被引文献84

  • 1任国莲,张淑秋.口服结肠定位给药系统的研究进展[J].中国药物与临床,2006,6(1):8-10. 被引量:10
  • 2张瑜,侯世祥,陈钢,卢懿,鞠静红.魔芋胶为载体的结肠定位给药系统体外释放介质研究[J].中国药学杂志,2006,41(8):604-607. 被引量:10
  • 3柏俊,孙备,吕凌,费勤志,陆忠祥.甲硝唑结肠定位缓释片的工艺研究[J].中国新药杂志,2006,15(24):2140-2143. 被引量:2
  • 4PINTO JF. Site-specific drug delivery systems within the gastro-intestinal tract : from the mouth to the colon [ J ]. Int J Pharm,2010,395(1 -2) :44 -52. 被引量:1
  • 5RABlSKOVA M, BAUTZOVA T, GAJDZIOK J,et al. Coatedchitosan pellets containing rutin intended for the treatment of in-flammatory bowel disease : In vitro characteristics and in vivo eval-uation[J]. Im J Pharm,2012, 422(1 -2) :151 - 159. 被引量:1
  • 6KUMAR P, MISHRA B. Colon targeted drug delivery systems-anoverview[ J]. Curr Drug Deliv,2008 ,5(3) : 186 - 198. 被引量:1
  • 7QURESHI AM, MOMIN M, RATHOD S, et al. Colon targeteddrug delivery system : a review on current approaches [ J ]. IndianJ Pharm,2013,1(4) :130 -147. 被引量:1
  • 8GAO B, FANG L, MEN J et al. Preparation of grafted micro-spheres CPVA-g-PSSS and studies on their drug-carrying and co-lon-specific drug delivery properties [ J ]. Mat Sci Eng : C, 2013 ,33(3) :1300 - 1306. 被引量:1
  • 9KOVACIC B, VRECER F, PLANINSEK 0. Design of a drugdelivery system with biomodal pH dependent release of a poorlysoluble drug[ J]. Die Pharmaize-An Int J Pharm Sci, 2011,66(6) :465 -466. 被引量:1
  • 10POZZI F, FURLANI P, GAZZANIGA A,et al. The time clocksystem: a new oral dosage form for fast and complete release ofdrug after a predetermined lag time [ J ]. J Control Release,1994, 31(1) :99 -108. 被引量:1

引证文献4

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部